Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inspire Medical Systems, Inc. Common Stock (NY:INSP)

41.99 -1.85 (-4.22%)
Official Closing Price Updated: 4:10 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems, Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
News headline image
Inspire Medical's Earnings Surge in Q4 ↗
The sleep apnea specialist's fourth-quarter results surpassed expectations. 
Via The Motley Fool
News headline image
Inspire Medical Systems’s (NYSE:INSP) Q4: Beats On Revenue
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24.5% year on year to $239.7 million. The company... 
Via StockStory
News headline image
4 Analysts Assess Inspire Medical Systems: What You Need To Know ↗
 
Via Benzinga
News headline image
Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Inspire Medical Systems (NYSE:INSP) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
News headline image
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (8 Ratings) ↗
 
Via Benzinga
News headline image
In the world of growth stocks, NYSE:INSP shines as a value proposition. ↗
Despite its growth, NYSE:INSP remains within the realm of affordability. 
Via Chartmill
News headline image
7 Analysts Have This To Say About Inspire Medical Systems ↗
 
Via Benzinga
News headline image
Why INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) qualifies as a high growth stock. ↗
Exploring INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP)'s high growth characteristics. 
Via Chartmill
News headline image
Earnings Scheduled For February 10, 2025 ↗
 
Via Benzinga
News headline image
Inspire Medical's Sleep Innovations Driving Big Gains ↗
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81. 
Via Investor's Business Daily
News headline image
Analyst Scoreboard: 7 Ratings For Inspire Medical Systems ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Inspire Medical Systems In The Eyes Of 7 Experts ↗
 
Via Benzinga
News headline image
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade ↗
BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion. 
Via Benzinga
News headline image
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Inspire Medical Systems Stock ↗
 
Via Benzinga
News headline image
Expert Ratings For Inspire Medical Systems ↗
 
Via Benzinga
News headline image
INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q2 2024 ↗
INSP stock results show that Inspire Medical Systems beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious ↗
Inspire Medical Systems recalls Model 3028 IPG due to manufacturing defect causing serious health risks. Learn about the FDA Class I recall implications and patient advisories. 
Via Benzinga
Topics Product Recall
News headline image
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
Via MarketBeat
News headline image
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗
 
Via Benzinga
News headline image
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again ↗
Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events. 
Via Investor's Business Daily
News headline image
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, ↗
Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter financial results. 
Via Benzinga
News headline image
7 Undervalued Stocks That Could Triple Your Money by 2026 ↗
These seven undervalued stocks have the potential to triple investors' money by 2026 once the market fully recognizes their value. 
Via InvestorPlace
News headline image
Dow Gains 150 Points; Emerson Electric Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.